Discover sustainable weight loss with Novo-lela - Combo 3, available at Slimgenix. This unique combination of 12mg Semaglutide and 4mg Cagrilintide leverages both medications’ strengths for optimum appetite and weight regulation. Semaglutide, a GLP-1 receptor agonist, effectively controls blood sugar and reduces appetite, while Cagrilintide, an amylin analogue, promotes satiety and slows gastric emptying. Both are injectable medications that target different pathways, providing a comprehensive approach to weight management and improved well-being. Transform your body with the power of GLP-1 therapy from Slimgenix.
Novo-lela - Combo 3 - 12mg Semaglutide & 4mg Cagrilintide
R3 450,00Price
Recommended Dosing Schedule Semaglutide:
Week 1–4 Weekly dose of 0.25 mg 6 units
Week 5–8 Weekly dose of 0.5 mg 13 units
Week 9–12 Weekly dose of 1 mg 25 units
Week 13–16 Weekly dose of 1.7 mg 43 units
Week 17+ Weekly dose of 2.4 mg 60 units
Recommended Dosing Schedule Cagrilintide:
Dosage Instructions: Dose escalation Weekly dose Units to inject via insulin needle.
Week 1–4 Weekly dose of 0.25 mg 18 units
Week 5–8 Weekly dose of 0.5 mg 38 units
Week 9–12 Weekly dose of 1 mg 75 units
